Indication
Renal Pelvis Urothelial Cancer
5 clinical trials
4 products
1 drug
Product
MitomycinClinical trial
uTRACT Jelmyto Registry: A Multicenter, Prospective and Retrospective Registry to Evaluate Real World Experience and Outcomes of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoStatus: Recruiting, Estimated PCD: 2025-04-01
Product
JelmytoClinical trial
A Randomized Trial Comparing Intravesical Gemcitabine to Continuous Bladder Irrigation With Sterile Water to Prevent Bladder Cancer Implantation in Patients Undergoing Excision of Upper Tract Urothelial CarcinomaStatus: Recruiting, Estimated PCD: 2027-11-01
Drug
GemcitabineClinical trial
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in CancerStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Preventing Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract: a Pilot Randomized Trial of a Single Prophylactic Bladder Instillation of Mitomycin C After Diagnostic UreteroscopyStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Product
Mitomycin C